[go: up one dir, main page]

MX2008007418A - Uso de las microesferas de carbono adsorbentes para el tratamiento del síndrome de intestino irritable. - Google Patents

Uso de las microesferas de carbono adsorbentes para el tratamiento del síndrome de intestino irritable.

Info

Publication number
MX2008007418A
MX2008007418A MX2008007418A MX2008007418A MX2008007418A MX 2008007418 A MX2008007418 A MX 2008007418A MX 2008007418 A MX2008007418 A MX 2008007418A MX 2008007418 A MX2008007418 A MX 2008007418A MX 2008007418 A MX2008007418 A MX 2008007418A
Authority
MX
Mexico
Prior art keywords
bowel syndrome
irritable bowel
treatment
carbon microspheres
adsorbent carbon
Prior art date
Application number
MX2008007418A
Other languages
English (en)
Inventor
Akiko Shibata
Laurent Fischer
Original Assignee
Ocera Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocera Therapeutics Inc filed Critical Ocera Therapeutics Inc
Publication of MX2008007418A publication Critical patent/MX2008007418A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen microesferas de carbono que son administradas para tratar síndrome de intestino irritable o síntomas asociados con síndrome de intestino irritable.
MX2008007418A 2005-12-06 2006-12-05 Uso de las microesferas de carbono adsorbentes para el tratamiento del síndrome de intestino irritable. MX2008007418A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74806505P 2005-12-06 2005-12-06
PCT/US2006/046623 WO2007067663A1 (en) 2005-12-06 2006-12-05 Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome

Publications (1)

Publication Number Publication Date
MX2008007418A true MX2008007418A (es) 2008-10-20

Family

ID=37873156

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008007418A MX2008007418A (es) 2005-12-06 2006-12-05 Uso de las microesferas de carbono adsorbentes para el tratamiento del síndrome de intestino irritable.

Country Status (7)

Country Link
US (2) US7749497B2 (es)
EP (1) EP1957090A1 (es)
AU (1) AU2006321870B2 (es)
CA (1) CA2632798A1 (es)
MX (1) MX2008007418A (es)
RU (1) RU2443424C2 (es)
WO (1) WO2007067663A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2632798A1 (en) 2005-12-06 2007-06-14 Ocera Therapeutics, Inc. Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome
WO2009049239A1 (en) * 2007-10-12 2009-04-16 Ocera Therapeutics, Inc. Use of adsorbent carbon microspheres to treat pouchitis
PT2538930T (pt) 2010-02-23 2016-08-05 Da Volterra Formulações para administração oral de adsorventes no intestino

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642986A (en) * 1970-04-01 1972-02-15 William Arthur Welch Aspirin-charcoal compositions
DE2715384C3 (de) * 1977-04-06 1981-10-01 Laves-Arzneimittel Gmbh & Co Kg, 3000 Hannover Arzneimittel gegen Diarrhöen
US4761284A (en) * 1977-12-27 1988-08-02 Kureha Kagaku Kogy Kabushiki Kaisha Antidote including activated carbon particles
RU2057533C1 (ru) 1992-07-26 1996-04-10 Владимир Григорьевич Николаев Активированный углеволокнистый энтеросорбент
CA2150184C (en) 1994-05-27 2006-12-05 Yasuo Uehara Pharmaceutical composition for the treatment of inflammatory bowel diseases
DE69519602T2 (de) * 1994-05-27 2001-05-10 Kureha Kagaku Kogyo K.K., Tokio/Tokyo Kugelförmige Aktivkohle zur Behandlung von Hämorrhoiden
FR2759294B1 (fr) * 1997-02-07 1999-04-30 Georges Serge Grimberg Composition oesogastro-intestinale a base de charbon dont les pores sont bouches par un enrobage, et qui peut etre utilisee seule ou en associatioin avec d'autres molecules
EP0958833A1 (en) 1998-05-20 1999-11-24 Erasmus Universiteit Rotterdam Methods and means for preventing or treating inflammation
US6830753B2 (en) * 2001-04-11 2004-12-14 Kureha Chemical Industry Co., Ltd. Adsorbent for oral administration
RU2253465C1 (ru) * 2003-09-25 2005-06-10 Сулима Маргарита Всеволодовна Способ лечения синдрома раздраженного кишечника
CA2632798A1 (en) 2005-12-06 2007-06-14 Ocera Therapeutics, Inc. Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome

Also Published As

Publication number Publication date
AU2006321870B2 (en) 2011-09-29
RU2008123889A (ru) 2010-01-20
RU2443424C2 (ru) 2012-02-27
EP1957090A1 (en) 2008-08-20
AU2006321870A1 (en) 2007-06-14
US20100266700A1 (en) 2010-10-21
US7749497B2 (en) 2010-07-06
WO2007067663A1 (en) 2007-06-14
CA2632798A1 (en) 2007-06-14
US20070141045A1 (en) 2007-06-21
US8075883B2 (en) 2011-12-13

Similar Documents

Publication Publication Date Title
NL301145I1 (es)
MY145070A (en) Imidazolothiazole compounds for the treatment of disease
MX2009006536A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2010002732A (es) Inhibidores de f1f0-atpasa y metodos relacionados.
MX2010003117A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
EA201200793A1 (ru) Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
PL2134704T3 (pl) Związki i kompozycje pełniące rolę modulatorów aktywności GPR119
TNSN08400A1 (en) Organic compounds and their uses
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
TW200738710A (en) Tricyclic inhibitors of 5-lipoxygenase
GEP20084520B (en) Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201200977A1 (ru) Лечение синдрома ли и ли-подобного синдрома токотриенолхинонами
ZA200903952B (en) Bicyclic compounds and use as antidiabetics
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
TN2011000482A1 (en) Organic compounds and their uses
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
GB0625648D0 (en) Compounds
TW200745124A (en) Azepinoindole derivatives as pharmaceutical agents
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
IN2012DN02471A (es)
IN2012DN00639A (es)

Legal Events

Date Code Title Description
FG Grant or registration